by Joe J.
NEOP has been publicly traded for 23 years. It has 50% market share in gamma probes, geiger counters that detect cancer during surgeries, so doctors can remove all the cancerous tissue. That’s the “razor”. It’s profitable, except for R&D expenses to develop the “razor blade”. Once you sell the [...]

• 4 Comments

Here are some low-priced stocks that I entered yesterday: ATML, STEC, ICO, ETFC, HMA, FCEL

• 0 Comments